Booz Allen Acquires Tracepoint, Bolstering Market Leadership in Cybersecurity
Combination will enable Booz Allen to deliver an unrivaled breadth and depth of cyber services…
Combination will enable Booz Allen to deliver an unrivaled breadth and depth of cyber services…
Visit Energous’ Booth (#51965) at the World Largest Consumer Electronics Show, Held Jan. 5-8 in…
First Installations of TurnOnGreen’s EV Smart Charging Stations Scheduled to Begin Late September 2021 at…
Acquisition expands the company’s capabilities in ultra-low temperature control; increases access to biopharma and other…
Expects full year 2021 net sales to be approximately $2.4 billion and net income to…
TPG Pace Tech Expects All Conditions to Be Met to Complete Business Combination Special Meeting…
HOUSTON–(BUSINESS WIRE)–JERA Americas Inc. (JERA Americas) the US-based subsidiary of global energy leader JERA Co.,…
Acquiring provider of home sleep apnea diagnosis solutions will allow ZOLL to better serve undiagnosed…
AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a…
DENVER, CO / ACCESSWIRE / September 13, 2021 / Solitario Zinc Corp. (“Solitario”) (NYSE American:XPL)(TSX:SLR)…
JACKSON CENTER, PA / ACCESSWIRE / September 13, 2021 / Halberd Corporation (OTC PINK:HALB) has…
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD…
Company Signs A 2nd Agreement With Nationally Recognized Solar Engineer, KMB Design Group, To Lead…
VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / BTU METALS CORP. (“BTU” or the…
VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / Patriot Battery Metals Inc. (the “Company”…
SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH)….
Cedar Clinical Research to Host Phase III Trial for Investigational Therapy for Schizophrenia TORONTO, ON…
MIAMI, FL / ACCESSWIRE / September 13, 2021 / TempuCheck (OTC PINK:STRH) is pleased to…
TAMPA, FL / ACCESSWIRE / September 13, 2021 / The Mosaic Company (NYSE:MOS) announced its…
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized…